These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6098107)

  • 21. Enterotoxemia associated with beta2 toxin-producing Clostridium perfringens type A in two Asiatic black bears (Selenarctos thibetanus).
    Greco G; Madio A; Martella V; Campolo M; Corrente M; Buonavoglia D; Buonavoglia C
    J Vet Diagn Invest; 2005 Mar; 17(2):186-9. PubMed ID: 15825503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic effects on bacterial viability, toxin production, and host response.
    Stevens DL; Bryant AE; Hackett SP
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S154-7. PubMed ID: 7548539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Production, purification and characterization of some Clostridium perfringens toxins].
    Capunzo M; Mariano A; Cavallo R
    G Batteriol Virol Immunol; 1982; 75(1-6):48-61. PubMed ID: 6315516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An activity which restores theta toxin activity in some theta toxin-deficient mutants of Clostridium perfringens.
    Imagawa T; Higashi Y
    Microbiol Immunol; 1992; 36(5):523-7. PubMed ID: 1513265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of protease on the production of Clostridium perfringens alpha toxin.
    Sato H; Yamakawa Y; Ito A; Murata R
    Jpn J Med Sci Biol; 1977 Feb; 30(1):44-6. PubMed ID: 195109
    [No Abstract]   [Full Text] [Related]  

  • 26. Brachyspira (Serpulina) pilosicoli of human origin interfere with the growth of Clostridium perfringens alpha-toxin producer.
    Calderaro A; Dettori G; Ragni P; Guégan R; Arcangeletti MC; Medici MC; Chezzi C
    New Microbiol; 2002 Apr; 25(2):139-47. PubMed ID: 12019719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of extracellular toxin production in Clostridium perfringens.
    Rood JI; Lyristis M
    Trends Microbiol; 1995 May; 3(5):192-6. PubMed ID: 7627457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regulation of the toxin production in Clostridium perfringens].
    Shimizu T
    Nihon Saikingaku Zasshi; 1995 Jul; 50(3):737-44. PubMed ID: 7474345
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxigenic characteristics of Clostridium perfringens type C in enterotoxemia of domestic animals.
    Niilo L
    Can J Vet Res; 1987 Apr; 51(2):224-8. PubMed ID: 2886206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biologic-economic study of processes for cultivating Clostridium perfringens. II. Comparison of the effectiveness of actual and predicted processes for cultivating microorganisms].
    Zaporozhtsev LN; Basnak'ian IA; Il'nitskaia EA; Vlasenko AP; Artem'eva TA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):37-43. PubMed ID: 200039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of Clostridium perfringens beta-toxin production by surface plasmon resonance immunoassay.
    Hsieh HV; Stewart B; Hauer P; Haaland P; Campbell R
    Vaccine; 1998; 16(9-10):997-1003. PubMed ID: 9682350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of antibiotics on the formation of toxin of Cl. perfringens type A].
    Vlasenko AP; Larina IA; Pavlova IB
    Antibiotiki; 1970 Sep; 15(9):790-3. PubMed ID: 4321365
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of peptidic groups isolated from enzymic casein hydrolysate on growth and toxinogenesis of Clostridium welchii (perfringens).
    Nekvasilová K; Sídlo J; Háza J
    J Gen Microbiol; 1970 Jul; 62(1):3-16. PubMed ID: 4321096
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of Clostridium perfringens alpha toxin by enzyme-linked immunosorbent assay.
    Naylor RD; Martin PK; Barker LT
    Res Vet Sci; 1997; 63(1):101-2. PubMed ID: 9368967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of alpha toxin from Clostridium perfringens: phospholipase C.
    Jolivet-Reynaud C; Moreau H; Alouf JE
    Methods Enzymol; 1988; 165():91-4. PubMed ID: 2906730
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibiotic-induced expression of a cryptic cpb2 gene in equine beta2-toxigenic Clostridium perfringens.
    Vilei EM; Schlatter Y; Perreten V; Straub R; Popoff MR; Gibert M; Gröne A; Frey J
    Mol Microbiol; 2005 Sep; 57(6):1570-81. PubMed ID: 16135225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weakly beta-haemolytic human intestinal spirochaetes antagonize the haemolytic activity of Clostridium perfringens alpha-toxin producer.
    Calderaro A; Dettori G; Grillo R; Cattani P; Ragni P; Guégan R; Fadda G; Chezzi C
    New Microbiol; 2001 Apr; 24(2):125-36. PubMed ID: 11346295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of cations on the letality and on the formation of the toxin of Pasteurella multocida].
    Erler W; Jacob B; Schlegel J
    Microbiol Res; 1994 Apr; 149(1):89-93. PubMed ID: 8087477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The necrotizing enteritis by Clostridium perfringens type C in piglets: II. Molecular epidemiology study].
    Gut P; Luginbühl A; Nicolet J; Boerlin P; Burnens AP
    Schweiz Arch Tierheilkd; 2002 Jun; 144(6):275-81. PubMed ID: 12125238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neonatal diarrhoea in pigs: alpha- and beta2-toxin produced by Clostridium perfringens].
    Hendriksen SW; van Leengoed LA; Roest HI; van Nes A
    Tijdschr Diergeneeskd; 2006 Dec; 131(24):910-3. PubMed ID: 17278609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.